Showing results (1491-1500 of 1,587) with videos related to
Sort By:
Pageof 159
Biorxiv : the Preprint Server for Biology|February 24, 2025
The MicroMap is a network visualisation resource for microbiome metabolismCyrille C Thinnes, Renee Waschkowitz, Eoghan Courtney, et al.Plos Neglected Tropical Diseases|February 16, 2024
Elimination of lymphatic filariasis as a public health problem in MalawiJohn Chiphwanya, Square Mkwanda, Storn Kabuluzi, et al.JAMA|January 17, 2023
Effect of Early High-Flow Nasal Oxygen vs Standard Oxygen Therapy on Length of Hospital Stay in Hospitalized Children With Acute Hypoxemic Respiratory Failure: The PARIS-2 Randomized Clinical TrialDonna Franklin, Franz E Babl, Shane George, et al.Lancet (London, England)|October 27, 2004
Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trialElliot Israel, Vernon M Chinchilli, Jean G Ford, et al.Science Immunology|August 8, 2017
Natural killer cell-mediated inflammation resolution is disabled in severe asthmaMelody G Duvall, Cindy Barnig, Manuela Cernadas, et al.Journal of Lipid Research|July 31, 2010
Lipidomics reveals a remarkable diversity of lipids in human plasmaOswald Quehenberger, Aaron M Armando, Alex H Brown, et al.Journal of the American Heart Association|May 7, 2019
Long-Term Follow-Up of Idiopathic Ventricular Fibrillation in a Pediatric Population: Clinical Characteristics, Management, and ComplicationsAntonio Frontera, Konstantinos Vlachos, Takeshi Kitamura, et al.NPJ Biofilms and Microbiomes|November 28, 2025
MicroMap: a network visualisation resource for human microbiome metabolismCyrille C Thinnes, Renee Waschkowitz, Eoghan Courtney, et al.The Journal of Allergy and Clinical Immunology|April 25, 2024
Utility of eosinophil peroxidase as a biomarker of eosinophilic inflammation in asthmaMonica Tang, Annabelle R Charbit, Mats W Johansson, et al.Chest|September 16, 2019
Estimated Ventricular Size, Asthma Severity, and Exacerbations: The Severe Asthma Research Program III CohortSamuel Y Ash, Gonzalo Vegas Sanchez-Ferrero, Mark L Schiebler, et al.Pageof 159